News

The growth of the medical device contract manufacturing (CMO) industry is being driven by increased outsourcing from original equipment manufacturers (OEMs), evolving healthcare demands, and the many benefits CMOs provide—such as scalability, flexibility, and the ability to quickly adapt to market shifts. By partnering with CMOs, medical device companies can concentrate on core competencies like research and development (R&D) and marketing, while benefiting from the expertise, cost-efficiency, and scalability offered by their partners.

The market is also being fueled by the rising demand for wearable medical technologies, advances in material science, and the increasing complexity of medical devices. Additionally, the growing need for personalized devices has further increased the reliance on contract manufacturing services. Strategic partnerships between OEMs and CMOs are expanding to meet global healthcare demands, while emerging medical device firms increasingly turn to outsourcing to support innovation and accelerate clinical trials. A growing number of market players are also contributing to development by offering design expertise and guidance—further boosting demand for contract manufacturing services.

Currently, the medical device CMO industry is in a mid-stage growth phase with an accelerating pace. This growth is shaped by factors such as mergers and acquisitions, innovation levels, regulatory pressures, and expansion into new products and regions.

Recent progress in wearable technology and IoT devices is reshaping R&D efforts, while innovations in AI and robotics are enabling faster, more efficient medical device development. These technologies support features like intuitive interfaces, longer battery life, low-power components, and cost-effectiveness.

However, the market must navigate stringent regulatory standards from global agencies such as the FDA, EU authorities, and others. Evolving guidelines around sustainability, safety, and efficacy are influencing compliance efforts, competition, and overall market dynamics.

Many small and mid-sized enterprises lack the necessary capital and infrastructure for full-scale device production, prompting increased collaborations, mergers, and acquisitions to expand capabilities. These partnerships contribute to a more competitive and innovative industry landscape.

As the demand for cost-effective, specialized medical devices grows, outsourcing is expected to rise. In response, CMOs are expanding globally—particularly into emerging markets—to tap into increasing patient needs, lower operating costs, and new opportunities, further fueling industry growth.

Source: Grand View Research